Michael J. Fisher, M.D.
Professor of Pediatrics (Oncology) at the Children's Hospital of Philadelphia
Attending Physician, Center for Childhood Cancer Research and Division of Oncology, Children's Hospital of Philadelphia
Member, Cancer Center, University of Pennsylvania
Director, Neurofibromatosis Program, Children’s Hospital of Philadelphia
Chief, Neuro-Oncology Section, Division of Oncology, Children’s Hospital of Philadelphia
Hubert J.P. and Anne Faulkner Schoemaker Endowed Chair in Pediatric Neuro-Oncology, Children’s Hospital of Philadelphia
Department: Pediatrics
Contact information
Center for Childhood Cancer Research and Division of Oncology
The Children’s Hospital of Philadelphia
The Hub for Clinical Collaboration - 3rd Floor
3500 Civic Center Blvd.
Philadelphia, PA 19104
The Children’s Hospital of Philadelphia
The Hub for Clinical Collaboration - 3rd Floor
3500 Civic Center Blvd.
Philadelphia, PA 19104
Office: (215)590-2800
Email:
fisherm@email.chop.edu
fisherm@email.chop.edu
Education
Eberhard-Karls Universitaet, Tubingen, Germany, 1987.
B.A. (Psychology, Summa cum Laude)
Amherst College, 1989.
M.D.
Harvard Medical School (cum Laude), 1994.
Permanent linkEberhard-Karls Universitaet, Tubingen, Germany, 1987.
B.A. (Psychology, Summa cum Laude)
Amherst College, 1989.
M.D.
Harvard Medical School (cum Laude), 1994.
Selected Publications
Abu-Arja MH, Rajabi Z, McGlynn MC, Ghebrelul RT, Zobeck M, Harasis S, Arora J, Zaghloul MS, Elhemaly A, Bertrand K, Gajjar A, Ronsley R, Cappellano AM, Dassi N, Czogala M, Graham RT, Knowles T, Mueller S, Fisher MJ, Finlay JL, Dhall G, Nagabushan S, Abdelbaki MS: Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors. J Neurooncol 177(3): 111, 2026.Hernáiz Driever P, Kordes UR, Brecht IB, Saletti V, Fisher MJ, Doughton G, Arefayene M, Rigazio A, Lluch N, Llorente N, Diede SJ, Salvador H.: Pharmacokinetics and Safety of Selumetinib Granule Formulation in Children with Symptomatic, Inoperable NF1-Related PN (SPRINKLE; Phase I/II). J Clin Oncol 44(10): 849-860, 2026.
Mandal AS, Shinohara RT, Jung B, Gardner M, Akouri HE, Yerys BE, Low KJ, Cole TJ, Guthrie W, Janke KM, Herrington JD, Hocking MC, Ball G, Payne JM, North KN, Muhlert N, Garg S, Seidlitz J, Fisher MJ, Alexander-Bloch AF: NF1-specific growth charts for head circumference over the first three years of life. Neurology 106(2): e214480, 2026.
Song JH, Baron J, Perez CC, Ramesh S, Minturn J, Desai KA, Shah AC, Belasco JM, Cole KA, Fisher MJ, Storm PB, Madsen PM, Kurtz G, Lustig RA, Hill-Kayser C, LaRiviere MJ: Feasibility and Safety of High-Dose Proton Re-Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single-Institution Retrospective Study. Pediatr Blood Cancer 73(7): e70371, 2026.
Avery RA, Gross AM, Cousineau-Krieger C, Keenan TDL, McManus T, Dallas CJ, Hampton C, Baldwin A, Jin F, Heisey K, Zeller K, Liu GT, Okeagu C, Bishop R, Fisher MJ, Widemann BC, Magone MT : Long-term Ophthalmic Safety in Children Treated with Mitogen-Activated Protein Kinase Pathway Inhibitors. Ophthalmology 133(2): 291-294, 2026.
Lamoureux AA*, Fisher MJ*, Lemelle L, Pfaff E, Amir-Yazdani P, Kramm C, De Wilde B, Kazanowska B, Hutter C, Pfister SM, Sturm D, Jones DTW, Orbach D, Pierron G, Raskin S, Drilon A, Diamond EL, Harada G, Zapotocky M, Zamecnik J, Krskova L, Ellezam B, Weil AG, Venne D, Barritault M, Leblond P, Coltin H, Hammad R, Tabori U, Hawkins C, Hansford JR, Meyran D, Erker C, McFadden K, Sato M, Gottardo NG, Dholaria H, Nørøxe DS, Goto H, Ziegler DS, Lin FY, Parsons DW, Lindsay H, Wong TT, Liu YL, Wu KS, Franson AT, Hwang E, Aguilar-Bonilla A, Cheng S, Cacciotti C, Massimino M, Schiavello E, Wood P, Hoffman LM, Cappellano A, Lassaletta A, Van Damme A, Llort A, Gerber NU, Spalato Ceruso M, Bendel AE, Skrypek M, Hamideh D, Mushtaq N, Walter A, Jabado N, Alsahlawi A, Farmer JP, Coleman C, Mueller S, Mazewski C, Aguilera D, Robison NJ, O'Halloran K, Abbou S, Berlanga P, Geoerger B, Øra I, Moertel CL, Razis ED, Vernadou A, Ducray F, Bronnimann C, Seizeur R, Clarke M, Resnick AC, Alves M, Jones C, Doz F, Laetsch TW, Perreault S: Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions. Clin Cancer Res 31(3): 561-572, 2025 Notes: *Co-first authors.
Kazerooni AF, Kraya A, Rathi KS, Kim MC, Vossough A, Khalili N, Familiar AM, Gandhi D, Khalili N, Kesherwani V, Haldar D, Anderson H, Jin R, Mahtabfar A, Bagheri S, Guo Y, Li Q, Huang X, Zhu Y, Sickler A, Lueder MR, Phul S, Koptyra M, Storm PB, Ware JB, Song Y, Davatzikos C, Foster JB, Mueller S, Fisher MJ, Resnick AC, Nabavizadeh A: Multiparametric MRI along with machine learning predicts prognosis and treatment response in pediatric low-grade glioma. Nat Commun 16(1): 340, 2025.
Nakhate V, Ly I, Muzikansky A, Rapalino O, Allen JC, Blakeley JO, Campian JL, Clapp DW, Dhall G, Jain RK, Karajannis MA, Packer RJ, Tonsgard J, Ullrich NJ, Korf BR, Fisher MJ, Plotkin SR, Neurofibromatosis Clinical Trials Consortium.: Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104. J Neurooncol 173(3): 751-757, 2025.
Barton B, Wolters PL Walsh KS, Ullrich NJ, Rosser T, Tonsgard J, Viskochil D, Schorry E,. Klesse LJ, Fisher MJ, Gutmann DH, Packer RJ, Korf B, Acosta MT, North KN, and Payne JM, for the NF Clinical Trials Consortium: Psychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairments. J Neuro-Oncology 174(1): 65-76, 2025.
Kazerooni AF, Kraya A, Rathi KS, Kim MC, Kesherwani V, Corbett R, Vossough A, Khalili N, Gandhi D, Familiar NKAM, Jin R, Huang X, Zhu Y, Sickler A, Lueder MR, Phul S, Storm PB, Ware JB, Foster JB, Mueller S, Rokita JL, Fisher MJ, Resnick AC, Nabavizadeh A: Imaging Clusters of Pediatric Low-Grade Glioma are Associated with Distinct Molecular Characteristics. Am J Neuroradiol 46(8): 1716-1725, 2025.